Related Experiment Video
Updated: Jan 9, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Dexmedetomidine for Alcohol Withdrawal: Looks Can Be Deceiving
Morgan Riggan1, Zachary Schmitz2, Robert S Hoffman3
1Department of Medicine, Division of Emergency Medicine, Western University Schulich School of Medicine and Dentistry, London, CAN.
Dexmedetomidine may not fully treat severe alcohol withdrawal symptoms, potentially leaving patients with psychological distress. Further research is needed to determine its role in managing alcohol withdrawal beyond vital signs.
Area of Science:
- Neuroscience
- Pharmacology
- Critical Care Medicine
Background:
- Alcohol withdrawal is a complex condition involving gamma-aminobutyric acid (GABA) receptor agonism and N-methyl-D-aspartate (NMDA) receptor antagonism.
- Benzodiazepines and barbiturates are standard treatments, but dexmedetomidine is being explored as an adjunct therapy.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Alcohol and Nicotine
Parenteral Anesthetics: Overview
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines

